Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Low molecular weight heparins versus new oral anticoagulants for long-term thrombosis prophylaxis and long-term treatment of DVT and PE: a review of the clinical and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2013 Authors' conclusions No relevant literature was identified regarding the comparative clinical and cost-effectiveness of LMWHs used as a single agent versus NOACs for long-term thrombosis prophylaxis and for long-term treatment of DVT and PE. Indexing Status Subject indexing assigned by CRD MeSH Administration, Oral; Anticoagulants; Heparin, Low-Molecular-Weights; Pulmonary Embolism; Venous Thrombosis Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000162 Date abstract record published 28/01/2014 |